Back

Transcriptomic profiles of ischemic and non-ischemic right ventricular heart failure

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (2) - Cardiac remodeling and multiorgan interactions in heart failure Genetics, Epigenetics, ncRNA ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Yvan Devaux

Luxembourg Institute of Health, Luxembourg (Luxembourg)

8 More presentations in this session

Presentation thumbnail
Discussant - Cardiac remodelling and multiorgan interactions in heart failure
Presentation thumbnail
A Novel CKD-HFpEF model for exploring neurogenic mechanisms in cardiorenal interactions: kidney surface ablation without renal nerve removal
Mr R. Miyamoto (Fukuoka, JP)
Abstract Slides Video
Presentation thumbnail
The cardio-hepatic interaction mediated by selenoprotein P is important for the pathogenesis of heart failure.
Associate Professor S. Usui (Kanazawa, JP)
Abstract
Presentation thumbnail
Nuclear AGO2 exacerbated high-fat diet-induced heart failure by activating transcription of HMGCS2 to promote ketogenesis in the heart
Doctor K. Jin (Wuhan, CN)
Abstract Slides Video
Presentation thumbnail
Takotsubo patient plasma induce endothelial eNOS-NO/ROS imbalance promoting monocyte and platelet adhesion: Protective effects of beta2-adrenergic receptor stimulation and SGLT2 inhibition
Ms S. Kerth (Munich, DE)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (2) - Cardiac remodeling and multiorgan interactions in heart failure

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Alternative RNA splicing in genetic and ischemic dilated cardiomyopathy
thumbnail
Congress Presentation
Times series clustering of right ventricular free-wall strain features for risk stratification in the general population
thumbnail
Congress Presentation
MicroRNA-based network analysis identified the NOVA1 gene as a potential new target in end-stage heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources